SRPT
Sarepta Therapeutics Inc
Price:  
123.46 
USD
Volume:  
1,033,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT EV/EBITDA

-106.8%
Upside

As of 2024-05-27, the EV/EBITDA ratio of Sarepta Therapeutics Inc (SRPT) is 13,249.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SRPT's latest enterprise value is 12,481.40 mil USD. SRPT's TTM EBITDA according to its financial statements is 0.94 mil USD. Dividing these 2 quantities gives us the above SRPT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the low predictability of business.

Range Selected
Trailing P/E multiples 16.2x - 24.9x 21.6x
Forward P/E multiples 20.1x - 27.7x 22.6x
Fair Price (8.43) - (8.31) (8.37)
Upside -106.8% - -106.7% -106.8%
123.46 USD
Stock Price
(8.37) USD
Fair Price

SRPT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 13,249.89
2024-05-23 13,618.14
2024-05-22 13,735.53
2024-05-21 13,817.81
2024-05-20 13,989.39
2024-05-17 14,044.58
2024-05-16 14,181.04
2024-05-15 14,156.96
2024-05-14 14,173.01
2024-05-13 14,076.69
2024-05-10 14,088.73
2024-05-09 14,136.89
2024-05-08 14,164.99
2024-05-07 14,512.16
2024-05-06 14,411.82
2024-05-03 14,273.35
2024-05-02 13,969.32
2024-05-01 13,996.42
2024-04-30 13,570.98
2024-04-29 13,785.70
2024-04-26 13,782.69
2024-04-25 13,644.22
2024-04-24 13,329.16
2024-04-23 12,613.74
2024-04-22 12,597.68
2024-04-19 12,463.23
2024-04-18 12,556.54
2024-04-17 12,691.00
2024-04-16 12,630.79
2024-04-15 12,733.14
2024-04-12 13,190.69
2024-04-11 13,349.23
2024-04-10 13,535.86
2024-04-09 13,603.08
2024-04-08 13,543.88
2024-04-05 13,512.78
2024-04-04 13,483.68
2024-04-03 13,597.06
2024-04-02 13,605.09
2024-04-01 13,745.57
2024-03-28 13,851.93
2024-03-27 13,929.19
2024-03-26 13,730.52
2024-03-25 13,699.41
2024-03-22 13,659.27
2024-03-21 13,398.39
2024-03-20 13,512.78
2024-03-19 13,310.09
2024-03-18 13,301.06
2024-03-15 13,208.75